No abstract available
MeSH terms
-
Adult
-
Anti-Allergic Agents / therapeutic use
-
Antineoplastic Agents / adverse effects
-
Cross Reactions
-
Desensitization, Immunologic / methods*
-
Drug Hypersensitivity / diagnosis
-
Drug Hypersensitivity / etiology
-
Drug Hypersensitivity / immunology
-
Drug Hypersensitivity / prevention & control*
-
Female
-
Filgrastim
-
Granulocyte Colony-Stimulating Factor / administration & dosage*
-
Granulocyte Colony-Stimulating Factor / adverse effects*
-
Granulocyte Colony-Stimulating Factor / immunology
-
Humans
-
Hypersensitivity, Immediate / chemically induced
-
Hypersensitivity, Immediate / diagnosis
-
Hypersensitivity, Immediate / immunology
-
Hypersensitivity, Immediate / prevention & control*
-
Immune Tolerance
-
Intradermal Tests
-
Lenograstim
-
Neutropenia / chemically induced
-
Neutropenia / drug therapy*
-
Predictive Value of Tests
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / immunology
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Anti-Allergic Agents
-
Antineoplastic Agents
-
Recombinant Proteins
-
Granulocyte Colony-Stimulating Factor
-
Lenograstim
-
Filgrastim